PharmaShots | Incisive News in 3 Shots

Subscribe Now

IMPOWER 24

Merck Pauses Enrollment in P-III (IMPOWER 22) and (IMPOWER 24) Clinical Trial of Islatravir for Pre-Exposure Prophylaxis of HIV-1 infection

Merck Pauses Enrollment in P-III (IMPOWER 22) and (IMPOWER 24) Clinical Trial of Islatravir for Pre-Exposure Prophylaxis of HIV-1...

December 7, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us